BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

3/4/2021

FDA Seeks Public Comment on Proposed Animal Food Labeling Regulations

The Food and Drug Administration (FDA) is seeking public comment on its proposed collection of information related to the labeling of color additives on animal food products, as required by the Paperwork Reduction Act of 1995. The agency is requesting public feedback on the proposed collection, which will be published in the Federal Register for 60 days.

3/4/2021

Treasury Adjusts Civil Monetary Penalties for Inflation

The US Department of the Treasury has published a final rule to update its civil monetary penalties for inflation, as mandated by the Federal Civil Penalties Inflation Adjustment Act of 1990, and will implement these changes through 2021.

3/3/2021

FDA Issues Final Debarment Order Against Michael Gurry

The FDA has permanently barred Michael Gurry from working with companies that have approved or pending drug applications, following his felony conviction under federal law, after he failed to respond to a 30-day notice period.

3/3/2021

FDA Issues Final Debarment Order Against Lawrence B. Ryan

The US Food and Drug Administration (FDA) has permanently barred Lawrence B. Ryan from providing services related to approved or pending drug applications, following his felony conviction under the Federal Food, Drug, and Cosmetic Act (FD&C Act)

3/3/2021

FDA Submits Collection of Information for Office of Management and Budget Review

The Food and Drug Administration has submitted a proposed collection of information to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995, with the goal of supporting cross-center collaboration on social behavioral sciences related to disease prevention, treatment, and the safety, efficacy, and usage of FDA-regulated products.

3/3/2021

Lemborexant Added to Schedule IV of Controlled Substances Act

The Drug Enforcement Administration has finalized a rule placing lemborexant, a medication used to treat sleep disorders, in Schedule IV of the Controlled Substances Act, effective immediately, following an interim rule published in 2020.

3/3/2021

DEA Proposes Adding 10 Fentanyl-Related Substances to Schedule I

The Drug Enforcement Administration (DEA) has proposed adding 10 specific fentanyl-related substances to Schedule I of the Controlled Substances Act, including compounds like 2'-fluoro ortho-fluorofentanyl and para-methylfentanyl, which are intended to combat the opioid crisis.